A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is an open, multi-center clinical trial, the purpose is to study the safety and
preliminary efficacy of Donafenib combined with KN046 in subjects with Advanced
Gastrointestinal Tumors.